Legend Biotech, founded in 2014, is a rapidly advancing multinational biopharmaceutical company headquartered in the United States. The company is focused on discovering and developing cutting-edge cell-based therapies to address critical health needs. Operating across vital sectors like Biotechnology, Health Care, and Life Sciences, Legend Biotech expertly navigates the complexities of the global healthcare industry.
With its corporate headquarters in Somerset, NJ, and manufacturing facilities strategically located in the United States, China, and Belgium, the company ensures a broad international footprint and streamlined operations. Recent funding activities include a significant $350.00M private placement VC investment secured in May 2023, underscoring investor confidence in its innovative pipeline and commercialization strategies.
Legend Biotech's commitment to leveraging cutting-edge technologies positions it as a compelling prospect for further investment, driven by a mission to yield impactful therapeutic advancements worldwide.